Cargando…

HIV-1 Envelope Subregion Length Variation during Disease Progression

The V3 loop of the HIV-1 Env protein is the primary determinant of viral coreceptor usage, whereas the V1V2 loop region is thought to influence coreceptor binding and participate in shielding of neutralization-sensitive regions of the Env glycoprotein gp120 from antibody responses. The functional pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Curlin, Marcel E., Zioni, Rafael, Hawes, Stephen E., Liu, Yi, Deng, Wenjie, Gottlieb, Geoffrey S., Zhu, Tuofu, Mullins, James I.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002983/
https://www.ncbi.nlm.nih.gov/pubmed/21187897
http://dx.doi.org/10.1371/journal.ppat.1001228
_version_ 1782193819871084544
author Curlin, Marcel E.
Zioni, Rafael
Hawes, Stephen E.
Liu, Yi
Deng, Wenjie
Gottlieb, Geoffrey S.
Zhu, Tuofu
Mullins, James I.
author_facet Curlin, Marcel E.
Zioni, Rafael
Hawes, Stephen E.
Liu, Yi
Deng, Wenjie
Gottlieb, Geoffrey S.
Zhu, Tuofu
Mullins, James I.
author_sort Curlin, Marcel E.
collection PubMed
description The V3 loop of the HIV-1 Env protein is the primary determinant of viral coreceptor usage, whereas the V1V2 loop region is thought to influence coreceptor binding and participate in shielding of neutralization-sensitive regions of the Env glycoprotein gp120 from antibody responses. The functional properties and antigenicity of V1V2 are influenced by changes in amino acid sequence, sequence length and patterns of N-linked glycosylation. However, how these polymorphisms relate to HIV pathogenesis is not fully understood. We examined 5185 HIV-1 gp120 nucleotide sequence fragments and clinical data from 154 individuals (152 were infected with HIV-1 Subtype B). Sequences were aligned, translated, manually edited and separated into V1V2, C2, V3, C3, V4, C4 and V5 subregions. V1-V5 and subregion lengths were calculated, and potential N-linked glycosylation sites (PNLGS) counted. Loop lengths and PNLGS were examined as a function of time since infection, CD4 count, viral load, and calendar year in cross-sectional and longitudinal analyses. V1V2 length and PNLGS increased significantly through chronic infection before declining in late-stage infection. In cross-sectional analyses, V1V2 length also increased by calendar year between 1984 and 2004 in subjects with early and mid-stage illness. Our observations suggest that there is little selection for loop length at the time of transmission; following infection, HIV-1 adapts to host immune responses through increased V1V2 length and/or addition of carbohydrate moieties at N-linked glycosylation sites. V1V2 shortening during early and late-stage infection may reflect ineffective host immunity. Transmission from donors with chronic illness may have caused the modest increase in V1V2 length observed during the course of the pandemic.
format Text
id pubmed-3002983
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-30029832010-12-27 HIV-1 Envelope Subregion Length Variation during Disease Progression Curlin, Marcel E. Zioni, Rafael Hawes, Stephen E. Liu, Yi Deng, Wenjie Gottlieb, Geoffrey S. Zhu, Tuofu Mullins, James I. PLoS Pathog Research Article The V3 loop of the HIV-1 Env protein is the primary determinant of viral coreceptor usage, whereas the V1V2 loop region is thought to influence coreceptor binding and participate in shielding of neutralization-sensitive regions of the Env glycoprotein gp120 from antibody responses. The functional properties and antigenicity of V1V2 are influenced by changes in amino acid sequence, sequence length and patterns of N-linked glycosylation. However, how these polymorphisms relate to HIV pathogenesis is not fully understood. We examined 5185 HIV-1 gp120 nucleotide sequence fragments and clinical data from 154 individuals (152 were infected with HIV-1 Subtype B). Sequences were aligned, translated, manually edited and separated into V1V2, C2, V3, C3, V4, C4 and V5 subregions. V1-V5 and subregion lengths were calculated, and potential N-linked glycosylation sites (PNLGS) counted. Loop lengths and PNLGS were examined as a function of time since infection, CD4 count, viral load, and calendar year in cross-sectional and longitudinal analyses. V1V2 length and PNLGS increased significantly through chronic infection before declining in late-stage infection. In cross-sectional analyses, V1V2 length also increased by calendar year between 1984 and 2004 in subjects with early and mid-stage illness. Our observations suggest that there is little selection for loop length at the time of transmission; following infection, HIV-1 adapts to host immune responses through increased V1V2 length and/or addition of carbohydrate moieties at N-linked glycosylation sites. V1V2 shortening during early and late-stage infection may reflect ineffective host immunity. Transmission from donors with chronic illness may have caused the modest increase in V1V2 length observed during the course of the pandemic. Public Library of Science 2010-12-16 /pmc/articles/PMC3002983/ /pubmed/21187897 http://dx.doi.org/10.1371/journal.ppat.1001228 Text en Curlin et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Curlin, Marcel E.
Zioni, Rafael
Hawes, Stephen E.
Liu, Yi
Deng, Wenjie
Gottlieb, Geoffrey S.
Zhu, Tuofu
Mullins, James I.
HIV-1 Envelope Subregion Length Variation during Disease Progression
title HIV-1 Envelope Subregion Length Variation during Disease Progression
title_full HIV-1 Envelope Subregion Length Variation during Disease Progression
title_fullStr HIV-1 Envelope Subregion Length Variation during Disease Progression
title_full_unstemmed HIV-1 Envelope Subregion Length Variation during Disease Progression
title_short HIV-1 Envelope Subregion Length Variation during Disease Progression
title_sort hiv-1 envelope subregion length variation during disease progression
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002983/
https://www.ncbi.nlm.nih.gov/pubmed/21187897
http://dx.doi.org/10.1371/journal.ppat.1001228
work_keys_str_mv AT curlinmarcele hiv1envelopesubregionlengthvariationduringdiseaseprogression
AT zionirafael hiv1envelopesubregionlengthvariationduringdiseaseprogression
AT hawesstephene hiv1envelopesubregionlengthvariationduringdiseaseprogression
AT liuyi hiv1envelopesubregionlengthvariationduringdiseaseprogression
AT dengwenjie hiv1envelopesubregionlengthvariationduringdiseaseprogression
AT gottliebgeoffreys hiv1envelopesubregionlengthvariationduringdiseaseprogression
AT zhutuofu hiv1envelopesubregionlengthvariationduringdiseaseprogression
AT mullinsjamesi hiv1envelopesubregionlengthvariationduringdiseaseprogression